About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pharmacokinetics of Levetiracetam (Keppra) in Neonates

Pharmacokinetics of Levetiracetam (Keppra) in Neonates

NCT01261416·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Children's Hospital Medical Center, Cincinnati

Age

0–0

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Gestational age ≥ 32 weeks
Postnatal age ≤ 30 days
Birth weight ≥ 2000 grams
Admitted to the NICU at Cincinnati Children's Hospital or Good Samaritan Hospital
Clinical or electrographic seizures of any etiology
Seizures or seizure prophylaxis requiring treatment with levetiracetam
Parental consent obtained

You may not be if

Infants with renal insufficiency indicated by serum creatinine \> 2.0 at any time
Infants who have previously received levetiracetam
Parents refuse consent
Attending physician does not wish the infant to be enrolled in the study
Infants who are currently receiving an investigational drug

The record

StatusCompleted

PhaseNo phase

Taking part18

StartedOct 2008

UpdatedDec 16, 2010

Conditions

Seizures Epilepsy

Where1

Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States